Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001809726-25-000004
Filing Date
2025-09-22
Accepted
2025-09-22 10:20:23
Documents
1
Effectiveness Date
2025-09-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10031
  Complete submission text file 0001809726-25-000004.txt   11139
Mailing Address 299 PAVONIA AVENUE 3-8 JERSEY CITY NJ 07302
Business Address 299 PAVONIA AVENUE 3-8 JERSEY CITY NJ 07302 201-344-7638
Claris Biotherapeutics, Inc. (Filer) CIK: 0001809726 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-558173 | Film No.: 251328844